Cinnamyl3 4-dihydroxyl-α-cyanocinnamate
WebCinnamyl-3,4-dihydroxy-α-cyanocinnamate; CAS No.:132465-11-3 with ≥98% (HPLC) purity. Buy from Sigma-Aldrich. WebCinnamyl-3,4-dihydroxy-α-cyanocinnamate Price - Select 2024 latest high quality Cinnamyl-3,4-dihydroxy-α-cyanocinnamate products in best price from global manufacturers, suppliers, wholesalers and factory on Chemsrc.com >>Mobile(AMP) version: Cinnamyl-3,4-dihydroxy-α-cyanocinnamate price.
Cinnamyl3 4-dihydroxyl-α-cyanocinnamate
Did you know?
WebNov 1, 2008 · C57Bl6/J mice were made diabetic with streptozotocin and maintained with or without the 12/15-lipoxygenase inhibitor cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC). WebDec 14, 2008 · Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) and nordihydroguaiaretic acid (NDGA), are common lipoxygenase inhibitors used in conjunction to study signaling …
WebCinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent and direct inhibitor of 5-LO (5-Lipoxygenase) that reduces 5-LO activity in cell-free assays. CDC also inhibits 12-LO … WebMar 29, 2011 · Europe PMC is an archive of life sciences journal literature.
WebMar 29, 2011 · cinnamyl-3,4-dihydroxy- -cyanocinnamate (CDC, Fig. 1) was reported to inhibit p12-LO with an IC 50 of 63 nM and to be selective about 30 and 53 times over 5- and 12/15-LO, respectively. This compound has been therefore used as pharmacological tool to identify 12-LO-mediated action and WebMar 29, 2011 · Lipoxygenases (LOs) are iron-containing enzymes that catalyze the conversion of arachidonic acid into hydroperoxyeicosatetraenoic acids (HPETEs) and …
WebJan 1, 2024 · 1. Introduction. The Knoevenagel condensation is a well-known organic reaction used in the synthesis of fine chemicals. Condensation reactions result in C-C bond formation which is a key step towards the production of end-products for application as perfumes [1], pharmaceuticals [2], and polymers [3].Industrially, it is for example applied …
WebJul 11, 2013 · An efficient method for the one-pot synthesis of 2-oxazolines from ethyl α-cyanocinnamate derivatives with acetamide and N-bromosuccinimide(NBS) in the presence of K3PO4 was developed. The reaction was performed smoothly and cleanly to give 2-oxazolines in good to excellent yields(up to 95%) in acetone at room temperature. … chronic worrierWebIt is shown that Cinnamyl-3,4-dihydroxy-α-cyanocinnamate is a potent inhibitor of 5-LO with efficacy in vivo and encourage further development of CDC as the lead compound. Lipoxygenases (LOs) are iron-containing enzymes that catalyze the conversion of arachidonic acid into hydroperoxyeicosatetraenoic acids (HPETEs) and other bioactive … chronic worryingWebJun 30, 2011 · Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) has been proposed as potent and selective inhibitor of platelet-type 12-LO (p12-LO). Here, we re-evaluated the … derivative of ln 3-xWebcinnamyl-3-4-dihydroxy- related products. MedChemExpress provides thousands of inhibitors, modulators and agonists with high purity and quality, excellent customer reviews, precise and professional product citations, tech support and prompt delivery. chronic worry counselling vancouverWebJan 31, 2014 · Europe PMC is an archive of life sciences journal literature. derivative of ln 3tWebCinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) has been proposed as potent and selective inhibitor of platelet-type 12-LO (p12-LO). Here, we re-evaluated the selectivity … derivative of ln 6WebCinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research … derivative of ln cos